{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:11:27Z","timestamp":1761862287040},"reference-count":0,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2003,10,31]],"date-time":"2003-10-31T00:00:00Z","timestamp":1067558400000},"content-version":"vor","delay-in-days":2160,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neuroendocrinology"],"published-print":{"date-parts":[[1997,12]]},"abstract":"<jats:p>Corticotrophin\u2010releasing hormone (CRH) and arginine vasopressin (AVP) are two potent stimulators for secretion of proopiomelanocortin (POMC)\u2010derived hormones, from corticotrophs. CRH also stimulates POMC synthesis. Atrial natriuretic peptide (ANP) has been reported to inhibit POMC peptide release and is thought to act through cGMP signalling pathways. A multicolumn cell perifusion system was used to investigate the role of cGMP signalling pathways in CRH\u2010 and AVP\u2010stimulated POMC peptide release from primary cultures of ovine or rat anterior pituitary cells. The CRH and\/or AVP stimulations were applied at 30\u2003min intervals as 5\u2003min pulses, and the various treatments were infused over a period of 50\u2003min, overlapping with 2 of the stimulations. ANP (10\u2003nM) had no effect on <jats:italic>\u03b2<\/jats:italic>\u2010endorphin (<jats:italic>\u03b2<\/jats:italic>EP) release from ovine cells, stimulated by 0.5\u2003nM CRH and 5\u2003nM AVP together, or 5\u2003nM CRH and 50\u2003nM AVP separately. Rat anterior pituitary cells were stimulated with 0.05\u2003nM CRH\/0.5\u2003nM AVP or 0.5\u2003nM CRH\/5\u2003nM AVP and treated with 1\u2003nM or 10\u2003nM ANP, respectively. No inhibition of ACTH or <jats:italic>\u03b2<\/jats:italic>EP was observed. Similarly, the nitric oxide donors molsidomine (100\u2003\u03bcM), SIN\u20101 (100\u2003\u03bcM) and NaNO<jats:sub>2<\/jats:sub> (100\u2003\u03bcM) did not inhibit <jats:italic>\u03b2<\/jats:italic>EP release stimulated by 0.5\u2003nM CRH\/5\u2003nM AVP in ovine cells. The cGMP analogues 8\u2010bromo\u2010cGMP (10\u2003\u03bcM and 100\u2003\u03bcM) and dibutyryl cGMP (100\u2003\u03bcM) also had no effect on <jats:italic>\u03b2<\/jats:italic>EP and ACTH release from ovine or rat anterior pituitary cells. Dexamethasone (8\u2003\u03bcM), a synthetic glucocorticoid known to block POMC synthesis and secretion of <jats:italic>\u03b2<\/jats:italic>EP and ACTH by a distinct mechanism, was used as a control and suppressed CRH\/AVP\u2010stimulated <jats:italic>\u03b2<\/jats:italic>EP secretion from ovine anterior pituitary cells. These results contrast with some previous studies and demonstrate that the cGMP signalling pathway in sheep or rat anterior pituitary cells does not directly inhibit secretion of POMC\u2010derived hormones from corticotrophs.<\/jats:p>","DOI":"10.1046\/j.1365-2826.1997.00665.x","type":"journal-article","created":{"date-parts":[[2003,11,2]],"date-time":"2003-11-02T16:50:02Z","timestamp":1067791802000},"page":"929-936","source":"Crossref","is-referenced-by-count":5,"title":["Atrial Natriuretic Peptide, Cyclic GMP Analogues and Modulation of Guanylyl Cyclase do not Alter Stimulated POMC Peptide Release From Perifused Rat or Sheep Corticotrophs"],"prefix":"10.1111","volume":"9","author":[{"given":"Maria E.","family":"Bowman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip J.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,10,31]]},"container-title":["Journal of Neuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2826.1997.00665.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2826.1997.00665.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2826.1997.00665.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T04:07:29Z","timestamp":1694405249000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2826.1997.00665.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,12]]},"references-count":0,"journal-issue":{"issue":"12","published-print":{"date-parts":[[1997,12]]}},"alternative-id":["10.1046\/j.1365-2826.1997.00665.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2826.1997.00665.x","archive":["Portico"],"relation":{},"ISSN":["0953-8194","1365-2826"],"issn-type":[{"value":"0953-8194","type":"print"},{"value":"1365-2826","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,12]]}}}